Back to Search Start Over

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.

Authors :
Tang G
Huang M
Luo Y
Liu W
Lin Q
Mao L
Wu S
Xiong Z
Hou H
Sun Z
Wang F
Source :
Frontiers in immunology [Front Immunol] 2021 Oct 29; Vol. 12, pp. 697622. Date of Electronic Publication: 2021 Oct 29 (Print Publication: 2021).
Publication Year :
2021

Abstract

Objectives: The longitudinal and systematic evaluation of immunity in coronavirus disease 2019 (COVID-19) patients is rarely reported.<br />Methods: Parameters involved in innate, adaptive, and humoral immunity were continuously monitored in COVID-19 patients from onset of illness until 45 days after symptom onset.<br />Results: This study enrolled 27 mild, 47 severe, and 46 deceased COVID-19 patients. Generally, deceased patients demonstrated a gradual increase of neutrophils and IL-6 but a decrease of lymphocytes and platelets after the onset of illness. Specifically, sustained low numbers of CD8 <superscript>+</superscript> T cells, NK cells, and dendritic cells were noted in deceased patients, while these cells gradually restored in mild and severe patients. Furthermore, deceased patients displayed a rapid increase of HLA-DR expression on CD4 <superscript>+</superscript> T cells in the early phase, but with a low level of overall CD45RO and HLA-DR expressions on CD4 <superscript>+</superscript> and CD8 <superscript>+</superscript> T cells, respectively. Notably, in the early phase, deceased patients showed a lower level of plasma cells and antigen-specific IgG, but higher expansion of CD16 <superscript>+</superscript> CD14 <superscript>+</superscript> proinflammatory monocytes and HLA-DR <superscript>-</superscript> CD14 <superscript>+</superscript> monocytic-myeloid-derived suppressor cells (M-MDSCs) than mild or severe patients. Among these immunological parameters, M-MDSCs showed the best performance in predicting COVID-19 mortality, when using a cutoff value of ≥10%. Cluster analysis found a typical immunological pattern in deceased patients on day 9 after onset, which was characterized as the increase of inflammatory markers (M-MDSCs, neutrophils, CD16 <superscript>+</superscript> CD14 <superscript>+</superscript> monocytes, and IL-6) but a decrease of host immunity markers.<br />Conclusions: This study systemically characterizes the kinetics of immunity of COVID-19, highlighting the importance of immunity in patient prognosis.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Tang, Huang, Luo, Liu, Lin, Mao, Wu, Xiong, Hou, Sun and Wang.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34777333
Full Text :
https://doi.org/10.3389/fimmu.2021.697622